Test Overview
Test Methodology

Chemiluminescent Immunoassay (CLIA)

Test Usage

May aid as a marker for prostate cancer. Do not use as a screening procedure as PSA has been observed in patient's with benign prostatic hypertrophy. Diagnostic PSA (DPSA) should be utilized for patients with a diagnosis of prostate cancer.

Reference Range *

MALE: Age 0 - 49 yrs: 0 - 2.5 ng/mL, Age 50 - 59 yrs: 0 - 3.5 ng/mL, Age 60 - 69 yrs: 0 - 4.5 ng/mL, Age 70 - 150 yrs: 0 - 6.5 ng/mL. FEMALE: Age 0 - 150 yrs: 0 - 0.1 ng/mL.

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Details
Days Set Up
Daily, 24 hours
Analytic Time

4 hours

Soft Order Code
DPSA
MiChart Code
PSA (Prostate Specific Antigen) - DIAGNOSTIC
Laboratory
Chemical Pathology
Section
Automation
Specimen Requirements
Collection Instructions

Collect specimen in an SST or red top tube. Centrifuge, aliquot serum into plastic vial. Refrigerate up to 8 hours or freeze for longer storage. Transport to MLabs as a frozen aliquot. Please indicate whether test is being orderd for Screening (PSA) or Diagnostic (DPSA) purposes.

Alternate Specimen
Red Top Tube
Yellow Top Tube
Normal Volume
0.50 mL serum
Minimum Volume
0.25 mL serum
Additional Information

Prostate Specific Antigen is a more sensitive marker of prostatic adenocarcinoma than Prostatic Acid Phosphatase.

Billing
CPT Code
G0103 PSA, 84153 DPSA
Fee Code
37919 PSA, 23374 DPSA
LOINC
2857-1
Resources